Found 19 matching trials
Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis) PHASE1 This will be a single center, bioequivalence and food-effect, open-label st...
Show More Learn More & Join Trial
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration PHASE1 The study is carried-out to describe and compare the plasma pharmacokinetic...
Show More Location
Department of Clinical Pharmacology
Learn More & Join Trial
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa PHASE1 To investigate the effect of three single oral doses of BIA 9-1067 (25 mg, ...
Show More Location
Algorithme Pharma Inc
Learn More & Join Trial
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients PHASE3 The purpose of this study is to determine whether the gastric retentive Acc...
Show More Location
University Alabama Hospital Neurology
Learn More & Join Trial
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off PHASE4 The purpose of this study is to test the effects of carbidopa/levodopa/enta...
Show More Learn More & Join Trial
The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics PHASE1 The purpose of this study is to determine the effect of repeated dosing of ...
Show More Learn More & Join Trial
Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease PHASE2 The objective of this study is to compare the pharmacokinetics and pharmaco...
Show More Location
Quest Research Institute
Learn More & Join Trial
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects PHASE3 The primary objective of this study was to demonstrate the superiority of l...
Show More Location
Site Reference ID/Investigator# 45931
Learn More & Join Trial
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD). PHASE3 This is a study to evaluate the safety and efficacy of IPX066 in advanced P...
Show More Learn More & Join Trial
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy PHASE3 The CELC200A2401 study has been designed in order to evaluate the hypothesi...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial